Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 5/20 | 0.51 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.49 |
| ▸ | KCNJ5 | P48544 | 1/20 | 0.47 |
| ▸ | KCNJ3 | P48549 | 1/20 | 0.47 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.47 |
| ▸ | KCND3 | Q9UK17 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.44 |
| ▸ | SCN1A | P35498 | 1/20 | 0.44 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.44 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30596267 | 1.00 | KCNA5 (0.51) | KCNA5KCNH2CYP2D6KCNE1KCNJ5 | |
| SCHEMBL1526122 | 0.91 | KCNA5 (0.50) | KCNA5KCNH2CYP2D6KCNE1KCNJ5 | |
| SCHEMBL7275282 | 0.91 | KCNA5 (0.50) | KCNA5KCNH2CYP2D6KCNE1KCNJ5 | |
| SCHEMBL8986648 | 0.89 | KCNA5 (0.49) | KCNA5KCNH2CYP2D6KCNE1KCNJ5 | |
| SCHEMBL7293012 | 0.89 | KCNA5 (0.49) | KCNA5KCNH2CYP2D6KCNE1KCNJ5 | |
| SCHEMBL16227724 | 0.87 | KCNA5 (0.47) | KCNA5KCNH2CYP2D6KCNE1KCNJ5 | |
| SCHEMBL28331181 | 0.87 | KCNA5 (0.47) | KCNA5KCNH2CYP2D6KCNE1KCNJ5 | |
| Hydrochloric Acid SCHEMBL8608055 | 0.87 | KCNA5 (0.47) | KCNA5KCNH2CYP2D6KCNE1KCNJ5 | |
| SCHEMBL6000906 | 0.87 | KCNA5 (0.47) | KCNA5KCNH2CYP2D6KCNE1KCNJ5 | |
| SCHEMBL31744336 | 0.86 | KCNA5 (0.52) | KCNA5KCNH2CYP2D6KCNE1KCNJ5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112724757-A | Ionomer coating for eliminating surface charge, preparation method thereof and corresponding coating | 徐宁 | 2021-04-30 | — | — | CN | claimed |
| US-20260078091-A1 | Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer | AMGEN INC (US) | 2026-03-19 | — | — | US | disclosed |
| US-20240300892-A1 | Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer | AMGEN INC (US) | 2024-09-12 | — | — | US | disclosed |
| EP-3483143-B1 | PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER | AMGEN INC (US) | 2023-10-18 | — | — | EP | disclosed |
| EP-3483143-B1 | PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER | AMGEN INC (US) | 2023-10-18 | — | — | EP | disclosed |
| WO-2023131530-A1 | A CLEANING COMPOSITION FOR METAL SUBSTRATES PRETREATMENT AND ITS PREPARATION METHOD AND APPLICATION THEREOF | BASF COATINGS GMBH (DE) | 2023-07-13 | — | — | WO | disclosed |
| EP-4092012-A1 | PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER | AMGEN INC. (US) | 2022-11-23 | — | — | EP | disclosed |
| EP-4092012-A1 | PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER | AMGEN INC. (US) | 2022-11-23 | — | — | EP | disclosed |
| US-20220169611-A1 | Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer | AMGEN INC (US) | 2022-06-02 | — | — | US | disclosed |
| US-20220169611-A1 | Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer | AMGEN INC (US) | 2022-06-02 | — | — | US | disclosed |
| US-20110195839-A1 | Liquid Aqueous Crop Protection Formulations | BASF SE (DE) | 2011-08-11 | — | — | US | disclosed |
| US-20110195846-A1 | Liquid Pyraclostrobin-Containing Crop Protection Formulations | BASF SE (DE) | 2011-08-11 | — | — | US | disclosed |
| EP-2348833-A2 | LIQUID AQUEOUS CROP PROTECTION FORMULATIONS | BASF SE (DE) | 2011-08-03 | — | — | EP | disclosed |
| EP-2346322-A2 | LIQUID PYRACLOSTROBIN-CONTAINING CROP PROTECTION FORMULATIONS | BASF SE (DE) | 2011-07-27 | — | — | EP | disclosed |
| WO-2010040835-A2 | LIQUID PYRACLOSTROBIN-CONTAINING CROP PROTECTION FORMULATIONS | BASF SE (DE) | 2010-04-15 | — | — | WO | disclosed |
| WO-2010040834-A2 | LIQUID AQUEOUS CROP PROTECTION FORMULATIONS | BASF SE (DE) | 2010-04-15 | — | — | WO | disclosed |
| CN-1201741-C | Agent for prevention and treatment of ischemia reperfusion disorder | CCI CORP (JP) | 2005-05-18 | — | — | CN | disclosed |
| CN-1125640-C | Prophylactic and therapeutic agent for inflammatory intestinal diseases | CCI CORP (JP) | 2003-10-29 | — | — | CN | disclosed |
| CN-1290169-A | Agent for prevention and treatment of ischemia reperfusion disorder | CCI CORP (JP) | 2001-04-04 | — | — | CN | disclosed |
| CN-1245430-A | Prophylactic and therapeutic agent for inflammatory intestinal diseases | CCI CORP (JP) | 2000-02-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240300892-A1 | Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer | MDM2, TP53, CDKN1A | KCNA5 4353/4885KCNH2 4697/4885CYP2D6 2390/4885 |
| US-20260078091-A1 | Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer | TP53, HIF1AN, MDM2 | KCNA5 3702/4885KCNH2 4455/4885CYP2D6 3100/4885 |
| US-20220169611-A1 | Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer | MDM2, TP53, CDKN1A | KCNA5 4353/4885KCNH2 4697/4885CYP2D6 2390/4885 |
| US-20110195839-A1 | Liquid Aqueous Crop Protection Formulations | AQP1, GANC, BROX | KCNA5 3061/4885KCNH2 2657/4885CYP2D6 3585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.